- Home
- KRMD vs KTTA Comparison
KRMD vs KTTA Comparison
Compare KRMD & KTTA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KRMD
- KTTA
- Stock Information
- Founded
- KRMD 1980
- KTTA 2020
- Country
- KRMD United States
- KTTA United States
- Employees
- KRMD N/A
- KTTA N/A
- Industry
- KRMD Medical/Dental Instruments
- KTTA Biotechnology: Pharmaceutical Preparations
- Sector
- KRMD Health Care
- KTTA Health Care
- Exchange
- KRMD Nasdaq
- KTTA Nasdaq
- Market Cap
- KRMD 113.5M
- KTTA N/A
- IPO Year
- KRMD N/A
- KTTA 2021
- Fundamental
- Price
- KRMD $2.42
- KTTA $1.54
- Analyst Decision
- KRMD Strong Buy
- KTTA
- Analyst Count
- KRMD 4
- KTTA 0
- Target Price
- KRMD $4.88
- KTTA N/A
- AVG Volume (30 Days)
- KRMD 151.1K
- KTTA 5.3M
- Earning Date
- KRMD 05-07-2025
- KTTA 05-13-2025
- Dividend Yield
- KRMD N/A
- KTTA N/A
- EPS Growth
- KRMD N/A
- KTTA N/A
- EPS
- KRMD N/A
- KTTA N/A
- Revenue
- KRMD $33,646,463.00
- KTTA N/A
- Revenue This Year
- KRMD $16.50
- KTTA N/A
- Revenue Next Year
- KRMD $15.47
- KTTA N/A
- P/E Ratio
- KRMD N/A
- KTTA N/A
- Revenue Growth
- KRMD 17.98
- KTTA N/A
- 52 Week Low
- KRMD $1.86
- KTTA $0.92
- 52 Week High
- KRMD $5.05
- KTTA $7.69
- Technical
- Relative Strength Index (RSI)
- KRMD 43.72
- KTTA 58.28
- Support Level
- KRMD $2.08
- KTTA $1.30
- Resistance Level
- KRMD $2.53
- KTTA $1.53
- Average True Range (ATR)
- KRMD 0.23
- KTTA 0.23
- MACD
- KRMD 0.05
- KTTA 0.03
- Stochastic Oscillator
- KRMD 78.32
- KTTA 38.46
About KRMD KORU Medical Systems Inc. (DE)
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).